Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Inhibitory activities of 3-trifluoromethyl benzamide derivatives against the entry of H5N1 influenza viruses].

Zhu Z, Cai Y, Yang J, Li X, Li R, Liu S.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(7):961-4. Chinese.

2.

[3-O-β-chacotriosyl benzyl ursolate inhibits entry of H5N1 influenza virus into target cells].

Song G, Shen X, Li Y, Zheng Y, Xiong P, Liu S.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jun;35(6):789-94. Chinese.

PMID:
26111672
3.

Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.

Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.

Peptides. 2011 Jul;32(7):1518-25. doi: 10.1016/j.peptides.2011.05.015. Epub 2011 May 19.

PMID:
21620914
4.

Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus.

Ding N, Chen Q, Zhang W, Ren S, Guo Y, Li Y.

Eur J Med Chem. 2012 Jul;53:316-26. doi: 10.1016/j.ejmech.2012.04.022. Epub 2012 Apr 21.

PMID:
22575533
5.

Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.

Zhu Z, Li R, Xiao G, Chen Z, Yang J, Zhu Q, Liu S.

Eur J Med Chem. 2012 Nov;57:211-6. doi: 10.1016/j.ejmech.2012.08.041. Epub 2012 Sep 7.

PMID:
23059548
6.

CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.

Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, Yang J, Poon VK, Zhou J, Chen M, Münch J, Kirchhoff F, Pleschka S, Haarmann T, Dietrich U, Pan C, Du L, Jiang S, Zheng B.

Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7. doi: 10.1016/j.ejphar.2011.04.013. Epub 2011 Apr 22.

PMID:
21536025
7.

Discovery of the first series of small molecule H5N1 entry inhibitors.

Song G, Yang S, Zhang W, Cao Y, Wang P, Ding N, Zhang Z, Guo Y, Li Y.

J Med Chem. 2009 Dec 10;52(23):7368-71. doi: 10.1021/jm900275m.

PMID:
19537689
8.

Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H(5)N(1).

Yang J, Yang JX, Zhang F, Chen G, Pan W, Yu R, Wu S, Tien P.

Bioorg Med Chem Lett. 2014 Jun 15;24(12):2680-4. doi: 10.1016/j.bmcl.2014.04.057. Epub 2014 Apr 24.

PMID:
24803363
9.

Structure-activity relationships of 3-O-β-chacotriosyl ursolic acid derivatives as novel H5N1 entry inhibitors.

Song G, Shen X, Li S, Li Y, Liu Y, Zheng Y, Lin R, Fan J, Ye H, Liu S.

Eur J Med Chem. 2015 Mar 26;93:431-42. doi: 10.1016/j.ejmech.2015.02.029. Epub 2015 Feb 20.

PMID:
25728024
10.

Super short membrane-active lipopeptides inhibiting the entry of influenza A virus.

Wu W, Wang J, Lin D, Chen L, Xie X, Shen X, Yang Q, Wu Q, Yang J, He J, Liu S.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt A):2344-50. doi: 10.1016/j.bbamem.2015.06.015. Epub 2015 Jun 16.

11.

Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell.

Zhu Z, Yao Z, Shen X, Chen Z, Liu X, Parquette JR, Liu S.

Eur J Med Chem. 2017 Apr 21;130:185-194. doi: 10.1016/j.ejmech.2017.02.040. Epub 2017 Feb 21.

PMID:
28246043
12.

Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor.

Chen Q, Guo Y.

ACS Infect Dis. 2016 Mar 11;2(3):187-93. doi: 10.1021/acsinfecdis.5b00139. Epub 2016 Feb 2.

PMID:
27623031
13.

A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission.

Wu R, Li X, Leung HC, Cao Z, Qiu Z, Zhou Y, Zheng BJ, He Y.

Antiviral Res. 2014 Jun;106:13-23. doi: 10.1016/j.antiviral.2014.03.005. Epub 2014 Mar 25.

PMID:
24681124
14.

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.

Cardoso FM, Ibañez LI, Van den Hoecke S, De Baets S, Smet A, Roose K, Schepens B, Descamps FJ, Fiers W, Muyldermans S, Depicker A, Saelens X.

J Virol. 2014 Aug;88(15):8278-96. doi: 10.1128/JVI.03178-13. Epub 2014 May 14.

15.

Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism.

Yang J, Chen G, Li LL, Pan W, Zhang F, Yang J, Wu S, Tien P.

Bioorg Med Chem Lett. 2013 May 1;23(9):2619-23. doi: 10.1016/j.bmcl.2013.02.101. Epub 2013 Mar 7.

PMID:
23538114
16.

New Carbocyclic Amino Acid Derivatives Inhibit Infection Caused by Highly Pathogenic Influenza A Virus Strain (H5N1).

Shibnev VA, Garaev TM, Deryabin PG, Finogenova MP, Botikov AG, Mishin DV.

Bull Exp Biol Med. 2016 Jun;161(2):284-7. doi: 10.1007/s10517-016-3396-0. Epub 2016 Jul 7.

PMID:
27383164
17.

Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.

Krajczyk A, Kulinska K, Kulinski T, Hurst BL, Day CW, Smee DF, Ostrowski T, Januszczyk P, Zeidler J.

Antivir Chem Chemother. 2014 Jan 29;23(4):161-71. doi: 10.3851/IMP2564.

PMID:
23538746
18.

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.

Kiso M, Takahashi K, Sakai-Tagawa Y, Shinya K, Sakabe S, Le QM, Ozawa M, Furuta Y, Kawaoka Y.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):882-7. doi: 10.1073/pnas.0909603107. Epub 2009 Dec 22.

19.

Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus.

Li S, Jia X, Shen X, Wei Z, Jiang Z, Liao Y, Guo Y, Zheng X, Zhong G, Song G.

Bioorg Med Chem. 2017 Aug 15;25(16):4384-4396. doi: 10.1016/j.bmc.2017.06.025. Epub 2017 Jun 15.

PMID:
28651913
20.

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.

Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J Jr.

Biochem Pharmacol. 2010 Feb 1;79(3):413-20. doi: 10.1016/j.bcp.2009.08.025. Epub 2009 Sep 2.

PMID:
19732754

Supplemental Content

Support Center